Series A - Resolution Therapeutics - 2020-12-02 - Crunchbase

Resolution Therapeutics raised $35559881 on 2020-12-02 in Series A. Syncona Partners LLP …

CouponFollow Extension

$35559881
OFF

Series A - Resolution Therapeutics - 2020-12-02 - Crunchbase

6 days from now

Resolution Therapeutics raised $35559881 on 2020-12-02 in Series A. Syncona Partners LLP …

crunchbase.com

£26
OFF

Resolution Therapeutics Announces A £26.6m Series A Financing …

6 days from now

London, 2 December 2020 – Resolution Therapeutics Limited (“Resolution”), a …

pharmiweb.com

£26
OFF

Resolution Therapeutics Announces A £26.6m Series A ... - Syncona

6 days from now

May 6, 2024 · 02.12.20. Share this page. ... Resolution Therapeutics; Resolution Therapeutics …

synconaltd.com

£10
OFF

Resolution Therapeutics Announces A £10m Extended Series A …

6 days from now

Apr 5, 2022 · – Broadening research pipeline into allogeneic macrophages for the treatment of …

resolution-tx.com

£63
OFF

News - Resolution Therapeutics

6 days from now

Resolution raises £63.5M series B financing from Syncona and appoints Paul Sekhri as Chair …

resolution-tx.com

$36
OFF

Resolution Raises $36M Series A For Macrophage Cell Therapy In …

6 days from now

LONDON – Syncona Ltd. has unveiled its fifth cell therapy startup, Resolution Therapeutics …

bioworld.com

$131
OFF

Resolution Therapeutics Stock Price, Funding, Valuation, Revenue ...

6 days from now

Oct 3, 2024 · Resolution Therapeutics has raised $131.8M over 5 rounds. Resolution …

cbinsights.com

£10
OFF

Resolution Therapeutics Announces A £10m Extended Series A

6 days from now

London, 5 April, 2022 – Resolution Therapeutics Limited (“Resolution”), a biopharmaceutical …

synconaltd.com

£26
OFF

Resolution Therapeutics Announces A £26.6m Series A Financing …

6 days from now

London, 2 December 2020 – Resolution Therapeutics Limited (“Resolution”), a …

resolution-tx.com

$13076904
OFF

Series A - Resolution Therapeutics - 2022-04-05 - Crunchbase

6 days from now

Apr 5, 2022 · Resolution Therapeutics raised $13076904 on 2022-04-05 in Series A. Syncona …

crunchbase.com

$70
OFF

The Week’s 10 Biggest Funding Rounds: Biotech Goes

6 days from now

Apr 28, 2023 · Founded in 2020, the company has raised more than $70 million, per …

crunchbase.com

$52000000
OFF

Series A - Genesis Therapeutics - 2020-12-02 - Crunchbase

6 days from now

Dec 2, 2020 · Genesis Therapeutics raised $52000000 on 2020-12-02 in Series A. Rock …

crunchbase.com

$29147914
OFF

Series B - Resolution Therapeutics - 2024-10-03 - Crunchbase

6 days from now

Oct 3, 2024 · Resolution Therapeutics raised $29147914 on 2024-10-03 in Series B. Search …

crunchbase.com

$126000000
OFF

Series A - Solve Therapeutics - 2022-01-21 - Crunchbase

6 days from now

Jan 21, 2022 · Solve Therapeutics raised $126000000 on 2022-01-21 in Series A. Search …

crunchbase.com

FAQs about Series A - Resolution Therapeutics - 2020-12-02 - Crunchbase Coupon?

What's new in Resolution Therapeutics in 2022?

In 2022, Resolution Therapeutics announced a £10M Series A extension to broaden its research pipeline into allogeneic macrophages for the treatment of liver disease. ...

Who is resolution Therapeutics?

Resolution Therapeutics is a biopharmaceutical company developing macrophage cell therapy to treat chronic diseases. View contacts for Resolution Therapeutics to access new leads and connect with decision-makers. Resolution Therapeutics is a biopharmaceutical company developing macrophage cell therapy to treat chronic diseases. ...

Is Resolution a company owned by Syncona?

London, 5 April 2022 – Resolution Therapeutics Limited (a biopharmaceutical company owned by Syncona Ltd, named as Syncona in the passage) is developing macrophage cell therapy to treat advanced liver disease. Today, they announced the completion of a £10m extension to the Series A financing from Syncona. ...

What does Series A funding mean for Resolution?

This extended Series A funding for Resolution will enable the company to continue to develop its autologous macrophage cell therapies and broaden its research activity into the development of an allogeneic platform to produce ‘off-the-shelf’ macrophage cell therapies. ...

What is Resolution TX?

Resolution is a company that discovers, develops, and takes to market macrophage cell therapies based on its proprietary platform of macrophage biology, cell engineering and manufacturing processes. www.resolution-tx.com Syncona (LON: SYNC) is a healthcare company focused on founding, building and funding a portfolio of global leaders in life science. ...

What's happening with Resolution?

Resolution is expanding the expertise within the organization and progressing its platform and programs. Edward Hodgkin, Partner of Syncona Investment Management Limited, who serves as Chairman and CEO of Resolution, added, 'There is strong momentum behind Resolution'. ...